These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 12628308)

  • 61. Covalent Immobilization of Antibodies through Tetrazine-TCO Reaction to Improve Sensitivity of ELISA Technique.
    García-Maceira T; García-Maceira FI; González-Reyes JA; Torres-Sánchez LA; Aragón-Gómez AB; García-Rubiño ME; Paz-Rojas E
    Biosensors (Basel); 2021 Dec; 11(12):. PubMed ID: 34940281
    [TBL] [Abstract][Full Text] [Related]  

  • 62. False reactivity in GTI Pak Plus ELISA kits due to the presence of anti-mouse antibody in patients' samples.
    Leach MF; Aubuchon JP
    Immunohematology; 2003; 19(4):112-6. PubMed ID: 15373675
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Development and Validation of an Enzyme-Linked Immunosorbent Assay for the Detection of Binding Anti-Drug Antibodies against Interferon Beta.
    Ingenhoven K; Kramer D; Jensen PE; Hermanrud C; Ryner M; Deisenhammer F; Pallardy M; Menge T; Hartung HP; Kieseier BC; Bertotti E; Creeke P; Fogdell-Hahn A; Warnke C
    Front Neurol; 2017; 8():305. PubMed ID: 28729851
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Countering immunotoxin immunogenicity.
    Flavell DJ
    Br J Cancer; 2016 May; 114(11):1177-9. PubMed ID: 27219287
    [No Abstract]   [Full Text] [Related]  

  • 65. Development of an enzyme-linked immunosorbent assay for measurement of serum-associated ALX40-4C.
    Payette PJ; Cormier M; Dabek B; Yungblut P; Presseault S; Climie S; Sahai J; Cameron WD; Filion LG
    Clin Diagn Lab Immunol; 1997 Nov; 4(6):671-5. PubMed ID: 9384287
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Discovery and customized validation of antibody targets by protein arrays and indirect ELISA.
    Sigdel TK; Sarwal MM
    Methods Mol Biol; 2013; 1034():373-84. PubMed ID: 23775752
    [TBL] [Abstract][Full Text] [Related]  

  • 67. The ELISA guidebook.
    Crowther JR
    Methods Mol Biol; 2000; 149():III-IV, 1-413. PubMed ID: 11028258
    [No Abstract]   [Full Text] [Related]  

  • 68. Histo-ELISA technique for quantification and localization of tissue components.
    Li Z; Goebel S; Reimann A; Ungerer M
    Sci Rep; 2020 Nov; 10(1):19849. PubMed ID: 33199754
    [TBL] [Abstract][Full Text] [Related]  

  • 69. 9th annual European Antibody Congress, November 11-13, 2013, Geneva, Switzerland.
    Reichert JM; Beck A; Lugovskoy AA; Wurch T; Coats S; Brezski RJ
    MAbs; 2014; 6(2):309-26. PubMed ID: 24492298
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Biomarkers of immunotoxicity in man.
    Kimber I
    Hum Exp Toxicol; 1995 Jan; 14(1):148-9. PubMed ID: 7748607
    [No Abstract]   [Full Text] [Related]  

  • 71. Anti-toxin antibody is not associated with recurrent Clostridium difficile infection.
    Gilbert J; Leslie J; Putler R; Weiner S; Standke A; Penkevich A; Keidan M; Young VB; Rao K
    Anaerobe; 2021 Feb; 67():102299. PubMed ID: 33227427
    [TBL] [Abstract][Full Text] [Related]  

  • 72. A high-affinity native human antibody neutralizes human cytomegalovirus infection of diverse cell types.
    Kauvar LM; Liu K; Park M; DeChene N; Stephenson R; Tenorio E; Ellsworth SL; Tabata T; Petitt M; Tsuge M; Fang-Hoover J; Adler SP; Cui X; McVoy MA; Pereira L
    Antimicrob Agents Chemother; 2015 Mar; 59(3):1558-68. PubMed ID: 25534746
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Cytotoxic activity of the recombinant anti-mesothelin immunotoxin, SS1(dsFv)PE38, towards tumor cell lines established from ascites of patients with peritoneal mesotheliomas.
    Li Q; Verschraegen CF; Mendoza J; Hassan R
    Anticancer Res; 2004; 24(3a):1327-35. PubMed ID: 15274292
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Antitumor activity of SS(dsFv)PE38 and SS1(dsFv)PE38, recombinant antimesothelin immunotoxins against human gynecologic cancers grown in organotypic culture in vitro.
    Hassan R; Lerner MR; Benbrook D; Lightfoot SA; Brackett DJ; Wang QC; Pastan I
    Clin Cancer Res; 2002 Nov; 8(11):3520-6. PubMed ID: 12429643
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Cytotoxic activity of disulfide-stabilized recombinant immunotoxin RFB4(dsFv)-PE38 (BL22) toward fresh malignant cells from patients with B-cell leukemias.
    Kreitman RJ; Margulies I; Stetler-Stevenson M; Wang QC; FitzGerald DJ; Pastan I
    Clin Cancer Res; 2000 Apr; 6(4):1476-87. PubMed ID: 10778980
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Pharmacokinetics and antitumor activity of a bivalent disulfide-stabilized Fv immunotoxin with improved antigen binding to erbB2.
    Bera TK; Viner J; Brinkmann E; Pastan I
    Cancer Res; 1999 Aug; 59(16):4018-22. PubMed ID: 10463601
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Tolerogenic nanoparticles restore the antitumor activity of recombinant immunotoxins by mitigating immunogenicity.
    Mazor R; King EM; Onda M; Cuburu N; Addissie S; Crown D; Liu XF; Kishimoto TK; Pastan I
    Proc Natl Acad Sci U S A; 2018 Jan; 115(4):E733-E742. PubMed ID: 29311317
    [TBL] [Abstract][Full Text] [Related]  

  • 78. An ELISA method for detection of human antibodies to an immunotoxin.
    Benbrook DM
    J Pharmacol Toxicol Methods; 2002; 47(3):169-75. PubMed ID: 12628308
    [TBL] [Abstract][Full Text] [Related]  

  • 79.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 80.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.